| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9ad271736b5af44ac98b04e055605fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-753 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-753 |
| filingDate |
1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8774fbbb8a6348c5fa4b8677d274e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1122dc3f1551be05087c7f34ca5c2761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c5b35e34c76a855fe2b060f0a17268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8281d3bd4f44520e9526da3c3bd44097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c191268420445735e7033447521f43a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb524cec5586f2f40a3a095be5ca69e |
| publicationDate |
1998-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0859641-A1 |
| titleOfInvention |
Dopamine transporter imaging agent |
| abstract |
Radiopharmaceutical compounds are disclosed. A tropane compound is linked through the N atom at the 8-position to a chelating ligand capable of complexing technetium or rhenium to produce a neutral labeled complex that selectively binds to the dopamine transporter. These compounds can be prepared as separate diastereoisomers as well as a mixture of diastereoisomers. Also disclosed are radiopharmaceutical kits for preparing the labeled radiopharmaceutical compounds. |
| priorityDate |
1995-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |